Pharmaceutical News

RSS

These programs put unused prescription drugs in the hands of patients in need

On a recent November evening, Angie Phoenix waited at a pharmacy here in Colorado's second-largest city to pick up prescription drugs to treat her high blood pressure and arm seizures.

6 Dec 2023

Study challenges link between proton pump inhibitors and kidney disease risk

A study in Scientific Reports investigates the association between proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RA) use on chronic kidney disease (CKD) risk.

5 Dec 2023

Medicare Part D found to over-reimburse pharmacies for generic drugs

Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022.

5 Dec 2023

Research shows how HIV drug could stop many coronavirus diseases

Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years.

5 Dec 2023

Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials

The safety, efficacy, and immunogenicity of a mRNA-based vaccine.

5 Dec 2023

MHRA's new measures aim to reduce valproate use and protect patients from harm

Other effective medicines are available for epilepsy and bipolar disorder and valproate should only be used if these don’t work or aren’t suitable for an individual patient.

4 Dec 2023

Exploring 'food noise': Study sheds light on eating thoughts and obesity treatment breakthroughs

Study delves into the concept of 'food noise,' referring to persistent thoughts about eating, and assesses its impact on eating behaviors and obesity treatments. It explores how GLP-1RAs, a class of drugs used for weight management, might influence food cue reactivity, potentially offering new insights into obesity treatment and the psychological aspects of eating behaviors.

30 Nov 2023

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Kidney stones affect nearly 10% of the global population. For more than three decades, thiazide diuretics, a common medication used for high blood pressure, have been the standard of care for kidney stone prevention because they reduce the excretion of urinary calcium.

30 Nov 2023

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited bioavailability. Nanocarriers like liposomes and nanoparticles improve TCM delivery, offering greater therapeutic effectiveness and reduced side effects, but face challenges in biocompatibility and stability for clinical use.

30 Nov 2023

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

For many people with migraine, it can be difficult to find a treatment that is effective and reliable, and information on how medications compare to one another is lacking.

29 Nov 2023

XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

A study posted to bioRxiv reveals that the monovalent XBB.1.5 vaccine booster significantly boosts neutralizing antibodies against new SARS-CoV-2 Omicron sub-variants. The research shows that both XBB.1.5 vaccination and infection elevate neutralizing titers, with the vaccine being particularly effective in infection-naïve individuals and those previously infected with Omicron.

29 Nov 2023

Macrocyclic compounds: A promising class of drugs for cancer treatment

This review was designed by Professor Xiaoling Song and Professor Biao Jiang and written by Pr. Xiaoling Song and a Ph.D. student, Yifan Wu (Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University) to summarize the application of macrocyclic molecules in cancer treatment.

29 Nov 2023

Research paves way for clinical trials of existing drugs for brain metastasis

The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease.

29 Nov 2023

Study finds no evidence to suggest cannabis reduces illicit opioid use

A 20-year Australian study has found no evidence to suggest cannabis reduces illicit opioid use, and it may not be an effective long-term method of reducing harm for those with an opioid use disorder or problematic use of opioids.

29 Nov 2023

People using ADHD medicines for a long time may have higher risk of cardiovascular diseases

A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year.

29 Nov 2023

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Study reveals that pregnant women infected with COVID-19 had a higher risk of preterm delivery, with significant health and socioeconomic implications. However, early vaccination adopters showed protection from these effects, highlighting the critical role of vaccines in safeguarding future generations' health, especially in the U.S., where the study was conducted.

28 Nov 2023

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Scientists have discovered new antiviral compounds from a rare bacterial strain, offering a novel approach to target hepatitis B virus. These compounds work by altering membrane permeability in infected cells, leading to the release of immature viral particles, a mechanism distinct from current HBV treatments.

28 Nov 2023

Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

28 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.

27 Nov 2023

Previous
1
...
30
31
32
33
34
35
36
...
1433
Next

Pharmaceutical News

These programs put unused prescription drugs in the hands of patients in need

Study challenges link between proton pump inhibitors and kidney disease risk

Medicare Part D found to over-reimburse pharmacies for generic drugs

Research shows how HIV drug could stop many coronavirus diseases

Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials

MHRA's new measures aim to reduce valproate use and protect patients from harm

Exploring 'food noise': Study sheds light on eating thoughts and obesity treatment breakthroughs

Genetic evidence suggests thiazide diuretics reduce kidney stone risk

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

Macrocyclic compounds: A promising class of drugs for cancer treatment

Research paves way for clinical trials of existing drugs for brain metastasis

Study finds no evidence to suggest cannabis reduces illicit opioid use

People using ADHD medicines for a long time may have higher risk of cardiovascular diseases

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News